Dr Maria Ott heads a junior research group at the Institute of Biochemistry and Biotechnology. She is investigating the self-assembly of various molecules. The mother of two has pursued her scientific career for many years, also on a part-time basis. Read more
Whether it has to do with the diesel scandal, brokerage costs or the sharing economy - the expertise of Professor Caroline Meller-Hannich is in demand when it comes to protecting consumers. She is just one of a handful of women whose expert opinions and statements are shaping German civil law. Read more
Professor Johanna Mierendorff has been the university’s Vice-President for Strategic Resource Planning since September 2018. We talked with the educational scientist about the challenges of career and junior staff development, gender equality, and a strategy for MLU. Read more
Over the past few years, legal expert Professor Kai-D. Bussmann and his colleagues, Andreas Schroth and Sebastian Oelrich, have been investigating how corruption can be prevented in business. They have introduced a new tool to improve corporate culture and are even launching a start-up for the project. Read more
When it comes to sexuality and gender roles, a fair share of people refer to the Holy Scripture. However, biblical scholar Professor Stefan Schorch says no clear answers are to be found in the Old or New Testament – and he explains why they shouldn’t be expected. Read more
Followers, likes and clicks are a reflection of influence on social media and therefore a measure of commercial success. But fame can be bought… Researchers from Halle and Sweden are studying the mechanisms of this digital market. Read more
In order to ensure that medicine only works where it is supposed to, researchers from Halle are investigating new ways to transport active ingredients. Read more
New active substances help combat dangerous bacteria that conventional antibiotics can no longer treat. These substances are being developed by Professor Andreas Hilgeroth’s team. Read more
René Wartner, Andreas Simon and Marcus Böhme have developed a technology that can be used to treat tumours with pinpoint accuracy. Their enzyme adhesive should allow toxins to bind to antibodies and be transported in a targeted way to cancer cells. The three biochemist entrepreneurs plan to market their idea. Read more
